6 Years Factory Ivermectin Vitamin AD3E Injection 100ml for Iran Factories

Short Description:


  • Price: FOB Shanghai: Discuss in Person
  • MOQ(50ml,100ml(g)): 5000 Bottle/Bag
  • MOQ(250ml,500ml(g)): 2000 Bottle/Bag
  • MOQ(5ml,10ml): 30000 Bottle/Vial
  • Shipment Port: Shanghai, Guangzhou, Chongqing, Yiwu
  • Payment Terms: T/T, L/C
  • Product Detail

    Send Message

    Related Video

    Feedback (2)

    [rand_pre] [rand_keywords], [rand_keywords], [rand_keywords], [rand_suffix]
    6 Years Factory Ivermectin Vitamin AD3E Injection 100ml for Iran Factories Detail:

    Formulation

    Ivermectin 10 mg, Vitamin A 250 000 I.U., Vitamin D3 37 500 I.U., Vitamin E 25 mg, slow release vehicle q.s.ad. 1 mL

    Indications

    For the treatment and control of internal (gastrointestinal and pulmonary nematodes) and external parasitosis (fly larvae causing myiasis, scabies, sucking lice, among others) and deficiencies of vitamins A, D3 and E. Its vehicle offers slow release and long action (at least 42 days).

    Dosage and Administration

    Cattle, camelids, sheep and goats: 1 mL/50 kg of b.w.; pigs: 1 mL/33 kg of b.w. Apply through subcutaneous or deep intramuscular route.

    Packing

    100 mL


    Product detail pictures:

    6 Years Factory
 Ivermectin Vitamin AD3E Injection 100ml for Iran Factories detail pictures

    6 Years Factory
 Ivermectin Vitamin AD3E Injection 100ml for Iran Factories detail pictures

    6 Years Factory
 Ivermectin Vitamin AD3E Injection 100ml for Iran Factories detail pictures


    Related Product Guide:

    [rand_pre] 6 Years Factory Ivermectin Vitamin AD3E Injection 100ml for Iran Factories, The product will supply to all over the world, such as: [rand_country], [rand_country], [rand_country], [rand_l_suffix]


  • TRACO 2014 – Non-small cell lung cancer; Topoisomerase

    Air date: Monday, December 01, 2014, 4:00:00 PM

    Category: TRACO

    Runtime: 01:55:14

    Description: TRACO

    Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in development and implementation of many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.

    For more information go to https://ccr.cancer.gov/trainee-resources-courses-workshops-traco

    Author: E. Szabo, NIH; Y. Pommier, NIH

    Permanent link: https://videocast.nih.gov/launch.asp?18752


    [rand_feedback]
    5 Stars By [rand_feedback_name] from [rand_country] - [rand_feedback_time]
    [rand_feedback]
    5 Stars By [rand_feedback_name] from [rand_country] - [rand_feedback_time]





    WhatsApp Online Chat !